SAFIRA

 (Safer Injection For Regional Anaesthesia)

Developed with The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust.

Current regional anaesthesia procedures require two operators: an anaesthetist who holds an ultrasound scanner and uses this to guide the needle tip placement and a second operator to inject the anaesthetic solution at a required pressure. It has been reported that anaesthetic solutions are often injected at high pressure. High pressure can cause damage to nerve fascicles, with serious nerve damage occurring in up to 1% of procedures and transient nerve damage in up to 8% of cases.

SAFIRA - Safer Injection System for Regional Anaesthesia - allows a single operator, an anaesthetist, to conduct the whole regional block at safe pressures. SAFIRA provides an end-to-end safety solution, collecting data on the whole  regional block procedure. 

Medovate is developing SAFIRA with the Queen Elizabeth Hospital Kings Lynn NHS Foundation Trust.

For further information view a short film on the SAFIRA technology.

Med Safira2

Register Interest

Medovate is an innovation development company dedicated to bringing novel medical technologies to market.